image credit: Unsplash

Biden proposes strengthening Medicare’s drug pricing power

March 7, 2024


With national polls showing Biden trailing former President Trump, Thursday’s State of the Union address is taking on outsized importance. Biden will be working to remind Americans of his accomplishments in office and persuade them that he can get even more done with another four years.

Both Republicans and Democrats overwhelmingly favor more regulation of prescription drug prices, according to polling by the Kaiser Family Foundation. Because of the IRA, Biden’s administration is the first to have the authority to negotiate prices on behalf of Medicare and began that process in August by releasing the list of the first 10 drugs to enter talks.

Read More on Biopharma Dive